Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
OKYO
#6046
OKYO Pharma Limited Ordinary Shares
1.7
1
0.00%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
0.00%
Monatliche Änderung
-23.32%
6 month change
-24.67%
Jahresänderung
+44.92%
Vorheriger Schlusskurs
1.7
1
Open
1.7
1
Bid
Ask
Low
1.7
1
High
1.7
1
Volumen
2
Märkte
Aktien
Gesundheitswesen
OKYO
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
1.37 B
25.55 M
33.84 M
37.61 M
—
Valuation ratios
Enterprise value
—
—
48.91 M
43.17 M
—
Price to earnings ratio
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
Price to book ratio
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
-1.26
2.56
10.9
1.28
—
Return on equity %
-1.84
-6.48
-2.86
-0.85
—
Return on invested capital %
—
—
—
—
—
Gross margin %
—
—
—
100
—
Operating margin %
—
—
—
-38.54 K
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
—
—
85.88 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
3.17
0.72
0.21
0.4
—
Inventory turnover
—
—
—
—
—
Asset turnover
0
0
0
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
Working capital per share
—
—
—
—
—
Book value per share
—
—
—
—
—
Nachrichten
Piper Sandler startet Coverage für OKYO Pharma mit ’Overweight’-Rating
Piper Sandler initiates OKYO Pharma stock with Overweight rating
OKYO Pharma-Aktie bricht nach Ankündigung einer Kapitalerhöhung über 20 Mio. US-Dollar ein
OKYO Pharma stock tumbles on $20 million public offering announcement
OKYO Pharma kündigt Aktienplatzierung im Wert von 20 Millionen US-Dollar an
OKYO Pharma announces $20 million public offering of ordinary shares
OKYO Pharma mandatiert Leerink Partners für ATM-Aktienangebot
OKYO Pharma transitions ATM equity offering to Leerink Partners as sales agent
OKYO Pharma verpflichtet Ex-Dompé-CMO Flavio Mantelli für Leitung des NCP-Programms
OKYO Pharma appoints former Dompé CMO Flavio Mantelli to lead NCP program
OKYO Pharma präsentiert Studienergebnisse zu Urcosimod auf jährlicher ASCRS-Tagung
OKYO Pharma to present urcosimod NCP study results at ASCRS meeting